Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

FDA Clinical Trials - A Timeline for Cancer versus Diseases Presently Targeted by Breathtec

Owlstone Ltd

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Lung Cancer Indicator Detection

Estimated Enrollment: 520
Study Start Date: October 2015
Estimated Study Completion Date: August 2020
Estimated Primary Completion Date: August 2019 (Final data collection date for primary outcome measure)

clinicaltrials.gov/ct2/show/NCT02612532?term=owlstone+medical&rank=1

Breathtec Biomedical Inc

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Infection Detection by Breath Analysis

Estimated Enrollment: 500
Study Start Date: November 2016
Estimated Study Completion Date: November 2018
Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)

clinicaltrials.gov/ct2/show/study/NCT02981550?view=results

Owlstone's Cancer study requires a 4 Year Primary Trial. Whereas, Breathtecs' targeted diseases require a 1 Year Primary Trial - in progress.

/////AMG